| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative
|
Perez, Marco V.
|
|
2013
|
166 |
3 |
p. 566-572.e1
5155 p.
|
artikel
|
| 2 |
A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis
|
Habara, Seiji
|
|
2013
|
166 |
3 |
p. 527-533.e2
52774 p.
|
artikel
|
| 3 |
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
|
Garcia, David A.
|
|
2013
|
166 |
3 |
p. 549-558
10 p.
|
artikel
|
| 4 |
Appropriate test selection for single-photon emission computed tomography imaging: Association with clinical risk, posttest management, and outcomes
|
Aldweib, Nael
|
|
2013
|
166 |
3 |
p. 581-588
8 p.
|
artikel
|
| 5 |
A prospective regional registry of ST-elevation myocardial infarction in Central Romania: Impact of the Stent for Life Initiative recommendations on patient outcomes
|
Benedek, Imre
|
|
2013
|
166 |
3 |
p. 457-465
9 p.
|
artikel
|
| 6 |
Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy
|
Kobayashi, Taisei
|
|
2013
|
166 |
3 |
p. 503-511
9 p.
|
artikel
|
| 7 |
Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy
|
Ndrepepa, Gjin
|
|
2013
|
166 |
3 |
p. 534-540
7 p.
|
artikel
|
| 8 |
Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation
|
Turakhia, Mintu P.
|
|
2013
|
166 |
3 |
p. 573-580
8 p.
|
artikel
|
| 9 |
Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial
|
Shah, Binita
|
|
2013
|
166 |
3 |
p. 519-526.e2
52082 p.
|
artikel
|
| 10 |
Correction
|
|
|
2013
|
166 |
3 |
p. 604-
1 p.
|
artikel
|
| 11 |
Correction
|
|
|
2013
|
166 |
3 |
p. 604-
1 p.
|
artikel
|
| 12 |
Differences in the outcome of patients undergoing percutaneous coronary interventions at teaching versus non-teaching hospitals
|
Sandhu, Amneet
|
|
2013
|
166 |
3 |
p. 401-408
8 p.
|
artikel
|
| 13 |
Documentation of study medication dispensing in a prospective large randomized clinical trial: Experiences from the ARISTOTLE Trial
|
Alexander, John H.
|
|
2013
|
166 |
3 |
p. 559-565.e1
5092 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2013
|
166 |
3 |
p. A6-
1 p.
|
artikel
|
| 15 |
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial
|
Brilakis, Emmanouil S.
|
|
2013
|
166 |
3 |
p. 474-480
7 p.
|
artikel
|
| 16 |
Embedding a randomized clinical trial into an ongoing registry infrastructure: Unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women)
|
Hess, Connie N.
|
|
2013
|
166 |
3 |
p. 421-428.e1
3860 p.
|
artikel
|
| 17 |
Evaluation of the dual peroxisome proliferator–activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: Rationale and design of the AleCardio trial
|
Lincoff, A. Michael
|
|
2013
|
166 |
3 |
p. 429-434.e1
3912 p.
|
artikel
|
| 18 |
Exercise-induced pulmonary hypertension in systemic sclerosis: A multifactorial entity
|
Baptista, Rui
|
|
2013
|
166 |
3 |
p. e13-
1 p.
|
artikel
|
| 19 |
Exercise-mediated changes in high-density lipoprotein: Impact on form and function
|
Blazek, Alisa
|
|
2013
|
166 |
3 |
p. 392-400
9 p.
|
artikel
|
| 20 |
High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men
|
Eggers, Kai M.
|
|
2013
|
166 |
3 |
p. 541-548.e1
4940 p.
|
artikel
|
| 21 |
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
|
Vriesendorp, Pieter A.
|
|
2013
|
166 |
3 |
p. 496-502
7 p.
|
artikel
|
| 22 |
Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial
|
Kirchhof, Paulus
|
|
2013
|
166 |
3 |
p. 442-448
7 p.
|
artikel
|
| 23 |
Information for Readers
|
|
|
2013
|
166 |
3 |
p. A7-
1 p.
|
artikel
|
| 24 |
Letter to the Editor regarding “Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium”
|
Blankfield, Robert P.
|
|
2013
|
166 |
3 |
p. e9-
1 p.
|
artikel
|
| 25 |
Morbidity in children and adolescents after surgical correction of truncus arteriosus communis
|
O'Byrne, Michael L.
|
|
2013
|
166 |
3 |
p. 512-518
7 p.
|
artikel
|
| 26 |
Overview of the 2012 Food and Drug Administration circulatory system devices panel meeting on the reclassification of external counterpulsation, intra-aortic balloon pump, and non–roller-type cardiopulmonary bypass blood pump devices
|
Minha, Sa'ar
|
|
2013
|
166 |
3 |
p. 414-420
7 p.
|
artikel
|
| 27 |
Predictors of discordance between physicians' and patients' appraisals of health-related quality of life in atrial fibrillation patients: Findings from the Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial
|
von Eisenhart Rothe, Alexander
|
|
2013
|
166 |
3 |
p. 589-596.e1
5372 p.
|
artikel
|
| 28 |
Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: Assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial
|
Mancini, G.B. John
|
|
2013
|
166 |
3 |
p. 481-487
7 p.
|
artikel
|
| 29 |
Race, exercise training, and outcomes in chronic heart failure: Findings from Heart Failure - A Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION)
|
Mentz, Robert J.
|
|
2013
|
166 |
3 |
p. 488-495.e1
4463 p.
|
artikel
|
| 30 |
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial
|
Kimmel, Stephen E.
|
|
2013
|
166 |
3 |
p. 435-441.e2
43666 p.
|
artikel
|
| 31 |
Regional systems of care for ST-elevation myocardial infarction: Do they save lives?
|
Henry, Timothy D.
|
|
2013
|
166 |
3 |
p. 389-391
3 p.
|
artikel
|
| 32 |
Renal dysfunction may predict new onset heart failure
|
Balta, Sevket
|
|
2013
|
166 |
3 |
p. e5-
1 p.
|
artikel
|
| 33 |
Response to letter by Balta et al regarding “Renal dysfunction and long-term risk of heart failure after coronary artery bypass grafting”
|
Holzmann, Martin J.
|
|
2013
|
166 |
3 |
p. e7-
1 p.
|
artikel
|
| 34 |
Response to letter by Messeri et al
|
Palmerini, Tullio
|
|
2013
|
166 |
3 |
p. e19-
1 p.
|
artikel
|
| 35 |
Response to Letter to the Editor by Blankfield regarding “Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium.”
|
White, William B.
|
|
2013
|
166 |
3 |
p. e11-
1 p.
|
artikel
|
| 36 |
Response to Letter to the Editor by Rui Baptista, M.D., Rogério Teixeira, M.D.
|
Gargani, Luna
|
|
2013
|
166 |
3 |
p. e15-e16
nvt p.
|
artikel
|
| 37 |
Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non–ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome trial
|
Bagai, Akshay
|
|
2013
|
166 |
3 |
p. 466-473.e1
4265 p.
|
artikel
|
| 38 |
Table of Contents
|
|
|
2013
|
166 |
3 |
p. A1-A5
nvt p.
|
artikel
|
| 39 |
The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial design, methods, and aims
|
Brand, Eva
|
|
2013
|
166 |
3 |
p. 449-456.e1
4112 p.
|
artikel
|
| 40 |
The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: From falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time?
|
Cai, Qiangjun
|
|
2013
|
166 |
3 |
p. 409-413
5 p.
|
artikel
|
| 41 |
The need to know crude event rates in meta-analysis
|
Messori, Andrea
|
|
2013
|
166 |
3 |
p. e17-
1 p.
|
artikel
|
| 42 |
Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience
|
Mampuya, Warner M.
|
|
2013
|
166 |
3 |
p. 597-603
7 p.
|
artikel
|
Tijdschrift beschrijving